- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 13.08. | Zomedica Corp.: Zomedica Announces Strategic Collaboration with Boehringer Ingelheim Animal Health Canada Inc. to Expand Equine Endocrine Diagnostic Testing Using TRUFORMA Platform | 778 | ACCESS Newswire | Collaboration with one of the world's largest animal health companies expected to accelerate TRUFORMA adoption, expand installed base, and drive recurring diagnostic revenue in Canada ANN ARBOR, MI... ► Artikel lesen | |
| 11.08. | Zomedica Corp.: Zomedica Announces "Fourth Friday at Four" Webinar on August 28, 2026: Zomedica International: Building a Global Platform for Veterinary Innovation | 777 | ACCESS Newswire | August session to spotlight Zomedica's international expansion strategy, distributor infrastructure, global market opportunity, and the commercial leadership driving growth across five continents ANN... ► Artikel lesen | |
| 05.08. | Zomedica Corp. - 8-K, Current Report | 1 | SEC Filings | ||
| 05.08. | Zomedica Corp.: Zomedica Announces Record Second Quarter Revenue of $9.5 Million, Up 37% Year-Over-Year, Net Loss Reduced 49%, with $44.1 Million in Liquidity | 453 | ACCESS Newswire | Zomedica surpasses $9 million in second quarter revenue for the first time while extending its record of consecutive year-over-year revenue growth to 22 quarters. ANN ARBOR, MI / ACCESS Newswire / August... ► Artikel lesen | |
| 05.08. | Zomedica Corp. - 10-Q, Quarterly Report | 3 | SEC Filings | ||
| 04.08. | Zomedica Corp.: Zomedica Launches the PulseVet Acoustic Muffler Accessory for PulseVet Shock Wave System | 379 | ACCESS Newswire | The accessory reduces sound in the treatment environment while maintaining the trusted efficacy of PulseVet shock wave therapy ANN ARBOR, MI / ACCESS Newswire / August 4, 2026 / Zomedica Corp. (OTCQB:ZOMDF)... ► Artikel lesen | |
| ZOMEDICA Aktie jetzt für 0€ handeln | |||||
| 15.07. | Zomedica Corp.: Zomedica Announces "Fourth Friday at Four" Webinar on July 24, 2026: Zomedica's Sales Organization - From Strategy to the Clinic | 471 | ACCESS Newswire | July session to spotlight the specialized, coordinated commercial organization that turns product innovation into clinical adoption, sustained utilization, and long-term recurring revenue ANN ARBOR... ► Artikel lesen | |
| 25.06. | Zomedica Corp.: Zomedica's Assisi Loop Products Designated "Fear Free" as Alliance to Advance Low Stress Care and Pet Wellbeing Continues with Fear Free, LLC | 391 | ACCESS Newswire | Collaboration with Fear Free and Zomedica reinforces Assisi Loop tPEMF therapy as a low-stress option for pets. ANN ARBOR, MI / ACCESS Newswire / June 25, 2026 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica"... ► Artikel lesen | |
| 11.06. | Zomedica Corp. - 8-K, Current Report | 2 | SEC Filings | ||
| 10.06. | Zomedica Corp.: Zomedica Announces "Fourth Friday at Four" Webinar on June 26, 2026: The Five Pillars of Zomedica - Framework for Clinical Value and Shareholder Returns | 418 | ACCESS Newswire | June session to present the strategic framework behind every Zomedica product and investment decision, connecting pet care outcomes, veterinary practice performance, and long-term recurring revenue... ► Artikel lesen | |
| 20.05. | Zomedica Corp.: Zomedica's PulseVet System Repeats as Official Shock Wave of the United States Eventing Association | 442 | ACCESS Newswire | Collaboration with USEA for Zomedica's PulseVet shock wave system will increase brand awareness among Eventing enthusiasts. ANN ARBOR, MI / ACCESS Newswire / May 20, 2026 / Zomedica Corp. (OTCQB:ZOMDF)... ► Artikel lesen | |
| 14.05. | Zomedica Corp.: Zomedica Announces "Fifth Friday at Four" Webinar on May 29th: First Quarter 2026 Financial Results and a Deep Dive into the Companion Animal VetTech Market | 1.005 | ACCESS Newswire | May session to review Q1 2026 financial results alongside an investor-focused look at the companion animal market for veterinary technology and Zomedica's integrated small-animal portfolio, spanning... ► Artikel lesen | |
| 06.05. | Zomedica Corp.: Zomedica Announces Record First Quarter Revenue of $8.8 Million, Reflecting 35% Annual Growth; and $47.5 Million in Liquidity | 983 | ACCESS Newswire | Zomedica surpasses $8 million in first quarter revenue for the first time and delivers record year-over-year revenue for 21st straight quarter. ANN ARBOR, MI / ACCESS Newswire / May 6, 2026 / Zomedica... ► Artikel lesen | |
| 06.05. | Zomedica reports Q1 results | 7 | Seeking Alpha | ||
| 06.05. | Zomedica Corp. - 8-K, Current Report | 3 | SEC Filings | ||
| 06.05. | Zomedica Corp. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 16.04. | Zomedica Corp.: Zomedica Announces "Fourth Friday at Four" Webinar on April 24th: A Behind-the-Scenes Look at Manufacturing Excellence and Operational Scale | 577 | ACCESS Newswire | April session to take investors inside Zomedica's manufacturing operations - showcasing quality systems, automation, and teams driving scalable product fulfillment providing substantial margins ANN... ► Artikel lesen | |
| 18.03. | Zomedica partners with Boehringer Ingelheim on equine testing | 7 | Investing.com | ||
| 18.03. | Zomedica Corp.: Zomedica Announces Strategic Collaboration with Boehringer Ingelheim to Expand Equine Endocrine Diagnostic Testing Using TRUFORMA Platform | 825 | ACCESS Newswire | Collaboration with one of the world's largest animal health companies expected to accelerate TRUFORMA adoption, expand installed base, and drive recurring diagnostic revenue ANN ARBOR, MI / ACCESS Newswire... ► Artikel lesen | |
| 17.03. | Zomedica reports Q4 results | 5 | Seeking Alpha |
1 2 3 Weiter >>
43 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 46,200 | -0,31 % | Fresenius macht weitere 300 Millionen Euro bei FMC zu Geld | Fresenius trennt sich von weiteren 7,8 Millionen Aktien der Fresenius Medical Care (FMC) und erlöst damit rund 300 Millionen Euro. Das Paket entspricht etwa 2,9 Prozent des ausgegebenen FMC-Grundkapitals... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,130 | -0,57 % | Fresenius Medical Care Announces Publication of a Multinational Real-World Evidence Study Associating High-Volume Hemodiafiltration with Lower Mortality Risk Than Conventional Hemodialysis | Publication in the Journal of the American Society of Nephrology reports that, in a large multinational real-world evidence study using a target trial emulation... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 39,260 | 0,00 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| HEARTFLOW | 48,100 | 0,00 % | Biotech Stocks At 52-Week Highs - Vogenx, Pharvaris, Solventum, Inhibikase Therapeutics, HeartFlow | WASHINGTON (dpa-AFX) - The following biotech stocks reached a 52-week high on August 24, 2026, driven by positive results from clinical trials or an upcoming conference participation. Vogenx... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 60,91 | 0,00 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 13,810 | -0,07 % | Aveanna Healthcare Holdings, Inc: Aveanna to Participate in the Deutsche Bank 2026 Healthcare Summit | ||
| ALIGNMENT HEALTHCARE | 13,565 | +0,04 % | Alignment Healthcare Reports Second Quarter 2026 Results, Surpassing High End of Guidance Across All Key Metrics | Generates $1.3 billion in total revenue, representing 31.6% growth year-over-year Grows Medicare Advantage membership 31.5% year-over-year to approximately 294,100 membersRaises the midpoint of all... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 32,180 | +2,88 % | 2,2 Milliarden Menschen mit Sehbeeinträchtigungen: Warum Augengesundheit für Carl Zeiss Meditec, Alcon & Co. zum Technologiemarkt wird - und wo Rise Nano Optics ins Spiel kommt | ||
| GERRESHEIMER | 26,520 | +4,41 % | EQS-Adhoc: Gerresheimer AG: Uwe Röhrhoff beendet Mandat als Interim-CEO | EQS-Ad-hoc: Gerresheimer AG / Schlagwort(e): Personalentscheidungen / Vorstand/Bedeutende Verträge
Gerresheimer AG: Uwe Röhrhoff beendet Mandat als Interim-CEO
24.08.2026 / 19:29... ► Artikel lesen | |
| BILLIONTOONE | 95,14 | -0,01 % | BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar | Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the nation's most accomplished leaders in oncology joins BillionToOne... ► Artikel lesen | |
| PROGYNY | 25,850 | 0,00 % | Progyny vor dem Boom?: Wells Fargo sieht bei dieser "Kinderwunsch-Aktie" 42 % Kurspotenzial | © Foto: SOPA Images - Sipa USAWells Fargo traut Progyny 42 Prozent Kurspotenzial zu. Das Geschäft mit Kinderwunsch-Leistungen könnte jetzt zum großen Wachstumstreiber werden Enthaltene Werte: US74340E1038Den... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 12,300 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 20,580 | -0,10 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| GENEDX | 89,24 | 0,00 % | GeneDx study shows rapid genome sequencing benefits beyond ICUs | ||
| NEUROONE MEDICAL TECHNOLOGIES | 1,980 | 0,00 % | EQS-News: NeuroOne Medical Technologies: NeuroOne Announces Successful Robotic-Assisted Drug Delivery Using Next-Generation StereoCED Platform | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Financial
NeuroOne Announces Successful Robotic-Assisted Drug Delivery Using Next-Generation StereoCED Platform 27.08.2026... ► Artikel lesen |
ZOMEDICA CORP gehört der Branche Gesundheitswesen an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ZOMEDICA CORP finden Sie auf Wallstreet Online.